Evidence map›Paper›PMID 37725308›Full record

ReviewAdvances in therapy2023

Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review.

Roger R Dmochowski, Diane K Newman, Eric S Rovner, Jacqueline Zillioux, Rena D Malik, A Lenore Ackerman

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Roger R DmochowskiDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Diane K NewmanPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Eric S RovnerDepartment of Urology, Medical University of South Carolina, Charleston, SC, USA.
Jacqueline ZilliouxDepartment of Urology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Rena D MalikDivision of Urology, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
A Lenore AckermanDepartments of Urology and Obstetrics and Gynecology, Division of Pelvic Medicine and Reconstructive Surgery, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, Box 951738, Los Angeles, CA, 90095-1738, USA. AAckerman@mednet.ucla.edu.
Medical University of South Carolina · USUniversity of California, Los Angeles · USUniversity of Maryland, Baltimore · USUniversity of Pennsylvania · USUniversity of Virginia · USVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anticholinergics have been used in the treatment of overactive bladder (OAB), but their use is limited by poor tolerability and anticholinergic-related side effects. Increasingly, providers are discontinuing anticholinergic prescribing because of growing evidence of the association of anticholinergic use with increased risk of cognitive decline and other adverse effects. Newer medications for OAB, the β

Indexed as

Urinary Bladder, OveractiveAdrenergic beta-3 Receptor AgonistsCholinergic AntagonistsHumansAdrenergic beta-3 Receptor AgonistsCholinergic AntagonistsAnticholinergic burdenDrug utilization managementInsuranceMedicarePrior authorizationβ3-adrenergic receptor agonists

Identifiers

PMID37725308
PMCPMC10567877
OpenAlexW4386847157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.